Price movement over the last 24 hours
Acadia Healthcare Company Inc vs Rocket Lab USA Inc — how do they compare? Acadia Healthcare Company Inc trades at $30.61 (market cap $2.94B), while Rocket Lab USA Inc trades at $83.1 (market cap $52.12B). The key difference: Rocket Lab USA Inc is far larger — about 17.7× Acadia Healthcare Company Inc's market cap, and Acadia Healthcare Company Inc is trading nearer its 52-week high, Rocket Lab USA Inc nearer its low. Which is the better fit depends on your goals.
| ACHC | RKLB | |
|---|---|---|
Market Cap | $2.94B | $52.12B |
Sector | Health | Technology |
52-Week High | $31.92 | $150.23 |
52-Week Low | $11.68 | $38.74 |
Enterprise Value | $5.45B | $50.87B |
Signals from Pluang's Aura AI — not financial advice
ACHC trades at $31.09, down 2.57% today but maintains a bullish technical outlook with strong moving average support. The company shows operational strength with three consecutive earnings beats, though profitability remains challenged with a -32.84% net margin. Analyst consensus is strongly bullish with 68% buy ratings, while recent news highlights the company's strategic shift toward profitability and rising behavioral health demand.
The stock presents a mixed opportunity with strong technical momentum and analyst support offset by persistent profitability challenges. Key catalysts include continued earnings outperformance and successful execution of the turnaround strategy, while risks center on margin pressures and high short interest that could limit upside potential.
Rocket Lab (RKLB) trades at $93.09, down 7.34% amid broader market pressure on space stocks. The stock shows bearish technical signals with key support at $90 and resistance at $96. Fundamentally, the company continues to operate at a loss with a negative net income margin of -26.87% despite recent mission successes for the Space Force. The $8 billion Iridium acquisition announcement positions Rocket Lab for vertical integration but adds significant financial complexity.
Wall Street maintains a bullish stance with 75% buy ratings and a $119.10 consensus target, representing 28% upside. However, execution risks from the massive acquisition, persistent cash burn, and rich valuation at 76x sales create substantial headwinds. The stock offers growth potential in the expanding space economy but requires careful risk management given current financial metrics.
Trailing returns across standard periods
Latest headlines on both assets
Acadia Healthcare is a leading provider of behavioral healthcare services across the US and Puerto Rico. It operates a network of psychiatric hospitals, residential treatment centers, and clinics for mental health and addiction recovery.
Read more on ACHC →Rocket Lab USA, Inc. is an aerospace manufacturer and small-satellite launch service provider. The company specializes in developing rockets for orbital launch, including its flagship *Electron* vehicle, and is developing the next-generation, reusable *Neutron* rocket. Beyond launch services, Rocket Lab also offers satellite design, manufacturing, and spacecraft component solutions, positioning itself as an end-to-end provider for the space industry.
Read more on RKLB →